Research.Patient.info
Generalized Myasthenia Gravis research hub
2 indexed studies · 1 currently recruiting
- active not recruitingPHASE3
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
This study is testing a new medicine called efgartigimod for people with a type of Myasthenia Gravis (MG). It checks how well it works and if it's safe compared to a dummy medicine. Some people will then get the new medicine openly.
United States · Belgium · Canada - enrolling by invitationPHASE2, PHASE3
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
This study looks at the long-term safety of two forms of a drug called efgartigimod for children and teenagers with a muscle weakness condition called generalised Myasthenia Gravis (gMG). Participants are those who have previously taken part in other efgartigimod studies.
United States · Belgium · Canada